Bioelectronics Corp Valuation
| BIEL Stock | USD 0.0003 0.0001 50.00% |
Bioelectronics Corp seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Bioelectronics Corp from analyzing the firm fundamentals such as Return On Asset of -0.34, operating margin of (0.09) %, and Shares Outstanding of 24.71 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bioelectronics Corp's price fluctuation is out of control at this time. Calculation of the real value of Bioelectronics Corp is based on 3 months time horizon. Increasing Bioelectronics Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioelectronics pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Bioelectronics Corp. Since Bioelectronics Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioelectronics Pink Sheet. However, Bioelectronics Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.0E-4 | Real 2.39E-4 | Hype 2.37E-4 | Naive 2.89E-4 |
The intrinsic value of Bioelectronics Corp's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bioelectronics Corp's stock price.
Estimating the potential upside or downside of Bioelectronics Corp helps investors to forecast how Bioelectronics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioelectronics Corp more accurately as focusing exclusively on Bioelectronics Corp's fundamentals will not take into account other important factors: Bioelectronics Corp Total Value Analysis
Bioelectronics Corp is currently forecasted to have valuation of 52.16 M with market capitalization of 12.35 M, debt of 13.34 M, and cash on hands of 925. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bioelectronics Corp fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
52.16 M | 12.35 M | 13.34 M | 925 |
Bioelectronics Corp Investor Information
The company had not issued any dividends in recent years. Based on the analysis of Bioelectronics Corp's profitability, liquidity, and operating efficiency, Bioelectronics Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Bioelectronics Corp Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioelectronics Corp has an asset utilization ratio of 144.35 percent. This suggests that the Company is making $1.44 for each dollar of assets. An increasing asset utilization means that Bioelectronics Corp is more efficient with each dollar of assets it utilizes for everyday operations.Bioelectronics Corp Profitability Analysis
The company reported the previous year's revenue of 1.61 M. Net Loss for the year was (289.82 K) with profit before overhead, payroll, taxes, and interest of 795.53 K.About Bioelectronics Corp Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Bioelectronics Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Bioelectronics Corp based exclusively on its fundamental and basic technical indicators. By analyzing Bioelectronics Corp's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Bioelectronics Corp's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bioelectronics Corp. We calculate exposure to Bioelectronics Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioelectronics Corp's related companies.BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Bioelectronics Corp's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bioelectronics Corp's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioelectronics Corp's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioelectronics Corp's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioelectronics Corp's revenue streams: Identify Bioelectronics Corp's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioelectronics Corp's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioelectronics Corp's growth potential: Evaluate Bioelectronics Corp's management, business model, and growth potential.
- Determine Bioelectronics Corp's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioelectronics Corp's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bioelectronics Corp Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bioelectronics Corp does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -38.3 M |
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.